Fig. 5: Disease-free survival based on the WHO 2017 groups and the alternative groups.
From: Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
a the WHO 2017 groups and b the alternative groups.
Fig. 5: Disease-free survival based on the WHO 2017 groups and the alternative groups. | Modern Pathology
